Voriconazole-induced Myositis in a Double Lung Transplant Recipient

Voriconazole is a triazole antifungal agent commercially approved in 2002. It is commonly used in immunocompromised patients as a therapeutic and prophylactic agent. We present the case of a 26-year-old Caucasian female who is a double lung transplant recipient who presented with complaints of gener...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Mohanad, Akanbi, Olalekan, Harding, Cameron, EL-Helw, Mohamed, Anstead, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445561/
https://www.ncbi.nlm.nih.gov/pubmed/30989007
http://dx.doi.org/10.7759/cureus.3998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445561/
https://www.ncbi.nlm.nih.gov/pubmed/30989007
http://dx.doi.org/10.7759/cureus.3998

Ejemplares similares